MALAT1 and glioblastoma: The following lncRNAs engaged in glioblastoma therapy resistance were selected: MALAT1, CASC2, H19, TUSC7, XIST, RP11-838N2.4, DLX6-AS1, GLIDR, MIR210HG, SOX2-OT (Zhang and Leung 2014; Peng et al. 2018).